Private-label potential ARKRAY USA is a private-label blood glucose meter manufacturer for the world’s largest retailer, indicating a strong channel for OEM partnerships and co-branding opportunities that can be expanded with additional testing devices or complementary diabetes care products.

Diversified diabetes aid Beyond glucose meters, ARKRAY has launched safety needles and swallowing aids, suggesting a pathway to expand to related diabetes care consumables and patient safety products in clinics and long-term care facilities.

Long-standing innovations With a history including the world’s first HbA1c analyzer and early long-term care glucose monitoring solutions, there is credibility for upsell into advanced diagnostics, point-of-care chemistry, and integrated care workflows.

Strategic partnerships Past collaborations with Rimidi and healthcare providers imply receptivity to ecosystem integrations, enabling sales plays around clinical management platforms, data analytics, and outcomes-focused bundles.

Mid-market focus Company size and revenue range position ARKRAY as a fit for mid-market health systems, clinics, and regional retailers seeking cost-effective diabetes care solutions, opening opportunities for bundled hardware, reagents, and support services.